BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 36977235)

  • 1. The Impact of Defect Size on Bone Healing in Critical-Size Bone Defects Investigated on a Rat Femur Defect Model Comparing Two Treatment Methods.
    Kammerer A; Hartmann FA; Nau C; Leiblein M; Schaible A; Neijhoft J; Henrich D; Verboket R; Janko M
    Bioengineering (Basel); 2024 Mar; 11(3):. PubMed ID: 38534561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant human erythropoietin as a promoter of bone healing in cats with femoral fractures.
    Vasileva R; Chaprazov T
    Open Vet J; 2024 Apr; 14(4):1012-1018. PubMed ID: 38808286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Erythropoietin-Promoted Fracture Healing on Bone Turnover Markers in Cats.
    Vasileva R; Chaprazov T; Milanova A
    J Funct Biomater; 2024 Apr; 15(4):. PubMed ID: 38667563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Healing of Critical-Sized Femoral Defects in Rats Treated with Erythropoietin Alone or in Combination with Xenograft.
    Vasileva R; Chaprazov T
    Vet Sci; 2023 Mar; 10(3):. PubMed ID: 36977235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Imaging Studies on Local and Systemic Erythropoietin Application for Promoting Bone Regeneration in Rat Calvarial Defects.
    Chaprazov T; Vasileva R; Atliev K; Firkova E
    Vet Sci; 2022 Oct; 9(10):. PubMed ID: 36288191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased bone formation in a rabbit long-bone defect model after single local and single systemic application of erythropoietin.
    Omlor GW; Kleinschmidt K; Gantz S; Speicher A; Guehring T; Richter W
    Acta Orthop; 2016 Aug; 87(4):425-31. PubMed ID: 27348783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single topical dose of erythropoietin applied on a collagen carrier enhances calvarial bone healing in pigs.
    Rölfing JH; Jensen J; Jensen JN; Greve AS; Lysdahl H; Chen M; Rejnmark L; Bünger C
    Acta Orthop; 2014 Apr; 85(2):201-9. PubMed ID: 24564750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
    Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrier membranes: More than the barrier effect?
    Omar O; Elgali I; Dahlin C; Thomsen P
    J Clin Periodontol; 2019 Jun; 46 Suppl 21(Suppl Suppl 21):103-123. PubMed ID: 30667525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemic erythropoietin treatment and heterogeneous xenograft in combination on bone regeneration of a critical-size defect in an experimental model.
    Diker N; Sarican H; Cumbul A; Kilic E
    J Craniomaxillofac Surg; 2018 Nov; 46(11):1919-1923. PubMed ID: 30301650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical-Size Bone Defects: Is There a Consensus for Diagnosis and Treatment?
    Nauth A; Schemitsch E; Norris B; Nollin Z; Watson JT
    J Orthop Trauma; 2018 Mar; 32 Suppl 1():S7-S11. PubMed ID: 29461395
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.